ambossIconambossIcon

Friedreich ataxia

Last updated: June 13, 2023

Summarytoggle arrow icon

Friedreich ataxia (FDRA) is an autosomal recessive disorder involving trinucleotide repeat expansion that leads to progressive neurodegeneration. It affects multiple spinal cord tracts, causing muscle weakness and impaired coordination of all limbs. A staggering gait in childhood is the resulting main symptom. Other features include skeletal abnormalities, cardiomyopathy, and diabetes. The clinical course is mainly determined by the extent of the loss of mobility and cardiac involvement. Diagnosis requires confirmation with genetic tests. Because there is no curative therapy available, the prognosis is poor.

Icon of a lock

Register or log in , in order to read the full article.

Epidemiologytoggle arrow icon

  • The most common autosomal recessive ataxia [1]
  • Peak incidence: 8–15 years (most cases < 25 years) [2][3]
  • Affects individuals of Central and Northern European descent [2]

Epidemiological data refers to the US, unless otherwise specified.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

References: [2][4]

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Individuals with FRiedreich ATAXia have ATAXic GAAit due to the expansion of the triplet GAA in the FRATAXin gene.

Icon of a lock

Register or log in , in order to read the full article.

Diagnosistoggle arrow icon

References:[4]

Icon of a lock

Register or log in , in order to read the full article.

Treatmenttoggle arrow icon

References:[4]

Icon of a lock

Register or log in , in order to read the full article.

Prognosistoggle arrow icon

References:[6]

Icon of a lock

Register or log in , in order to read the full article.

Preventiontoggle arrow icon

  • Carrier testing of relatives
  • Prenatal testing: Genetic counseling is recommended for parents with one affected child.

References:[6]

Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer